Stay updated on Glycine Supplement for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.

Latest updates to the Glycine Supplement for Severe COVID-19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThis release adds Revision: v3.4.2 and removes an earlier funding notice, which are site-wide updates and do not modify the study page content or its data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice with links to cc.nih.gov and updated the site revision to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' toggle and updated capitalization for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision footer now shows 'Revision: v3.4.0' instead of 'v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a minor site-versioning update with no impact on the study details or user actions.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check71 days agoChange DetectedPublications section updated: added a new Biol Trace Elem Res article (2025) and replaced the previous 'Online ahead of print' entry with the finalized 2025 publication details, including the DOI.SummaryDifference0.0%

Stay in the know with updates to Glycine Supplement for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.